Can You Advertise Menopause HRT on Meta?

What this means for you

• Menopause care ads run without authorization. Meta exempts ads that promote telehealth services generally, and its reproductive health rules allow products and services addressing the effects of menopause for people 18 and over.
• Naming a prescription hormone makes it a prescription drug ad: active LegitScript certification, Meta's authorization, 18+, the US, Canada or New Zealand, and a consult-a-professional disclaimer.
• "Hot flashes keeping you up?" implies a medical condition and fails. "Menopause care from licensed clinicians" passes.
• Weight and body claims bring in Meta's weight loss rules: no statements of inferiority about appearance, no pinching-fat close-ups, and no timed outcome promises without qualifiers.
• Compounded "bioidentical" hormones are compounded, not FDA-approved. The FDA says it has no evidence they are safer or more effective than approved hormone therapy.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs Meta for women's health brands that offer menopause and perimenopause care online. This page sets out the Meta rules that decide what those brands can say, to whom, and when, plus the FDA facts that shape the claims. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

Menopause is named in Meta's policy

Meta's Health and Wellness policy has an Adult Products and Reproductive Health section. When targeting people 18 or older, it allows ads that promote sexual and reproductive health and wellness products or services "as long as the focus is on health and the medical efficacy of the product or the service and not on the sexual pleasure or enhancement". Its list of products addressing reproductive health issues includes the effects of menopause, next to pain relief during sex and Hypoactive Sexual Desire Disorder. For treatments that need a prescription, the section points to the Drugs and Pharmaceuticals policy.

The prescription hormone gate

Meta's Drugs and Pharmaceuticals policy requires online pharmacies and telehealth providers to be actively certified with LegitScript and authorized by Meta before running ads that promote prescription drugs. Authorized ads may only target people 18 or older, only in the United States, Canada or New Zealand, and only where the advertiser is certified, and each needs a disclaimer to consult a licensed health professional or obtain a valid prescription. Ads that promote telehealth services generally need no authorization.

LegitScript's write-up of its telehealth advertising webinar notes that on Meta most telehealth providers classify as telemedicine providers rather than pharmacies unless they own and operate their own pharmacy, and that the classification decides which treatments can be promoted and what documentation is required. In practice a menopause brand runs a care layer now, about the clinicians, the visit, follow-up and the price, and adds product ads in their own ad sets once authorization is live.

Personal attributes: describe the care, not the reader

Meta's personal attributes policy bars ads that assert or imply a person's physical or mental health, including medical conditions, and its age examples follow the same logic: "Ready to upgrade your skin to look younger?" fails. Meta does allow a passing reference to gender, age groups or age ranges, and "you" or "your" with no attribute attached.

• Fails: "Hot flashes keeping you up?", "Are you in perimenopause?", "Tired of feeling like this?"
• Passes: "Menopause care from licensed clinicians", "Midlife women's health, with labs and follow-up", "Talk to a clinician about menopause treatment options".

Body-related claims

Many menopause programs talk about weight. Once an ad promotes weight loss, Meta's weight loss rules apply alongside everything above. Ads can't contain statements of inferiority about physical appearance, meaning negative terms or questions that attack a person's appearance or body parts, can't show close-ups that pinch fat, and can't use clickbait such as sensational claims or promises of a specific outcome within a set timeframe without disclaimers or qualifiers. Prescription weight loss products also follow the Drugs and Pharmaceuticals policy.

Since July 22, 2026, Meta lets 18+ dietary weight loss ads show people using the product or service and its impact, and state the time taken to see noticeable results. MedScale's own rule is stricter: our ads don't show body transformation. That is our choice, not Meta's rule. Meta also bars claims to cure, heal or eliminate a short list of conditions that includes thyroid conditions and diabetes; claims about managing symptoms are outside that rule.

What the FDA's 2026 label change means for ads

In November 2025 the FDA began removing broad boxed warnings from menopausal hormone therapy products, and on February 12, 2026 it announced approved labeling changes for the first six products, removing risk statements about cardiovascular disease, breast cancer and probable dementia from the boxed warning. The FDA said it was not seeking to remove the boxed warning for endometrial cancer on systemic estrogen-alone products, and it encouraged women to consult the drug label for the benefits and risks.

That is a label change, not a licence for new claims. "The FDA says HRT is safe" overstates it, and it reads as the kind of sensational health claim Meta's clickbait rule bars. Copy can say that FDA-approved hormone therapy is an option to discuss with a licensed clinician, and the landing page can carry the label-based risk information.

Compounded bioidentical hormones

The FDA's menopause page says many products marketed as "bioidentical hormones" are compounded drugs, which are not FDA-approved, and that the FDA has no evidence that compounded bioidentical hormones are safe and effective, or safer or more effective than FDA-approved hormone therapy. It also says there are no FDA-approved drugs containing estriol. Any ad or page that names a compounded hormone should call it compounded, not FDA-approved, and never imply it is safer or more natural than approved therapy.

What still gets rejected

• Hooks that ask about the reader's symptoms, cycle or body.
• Ads that name or price a prescription hormone before LegitScript certification and Meta's authorization.
• Weight claims that attack appearance, pinch fat, or promise a result by a date.
• Pleasure or enhancement framing for libido or intimacy care.
• Pixel events or URLs that carry a condition, a cycle or a treatment. Meta lists sexual and reproductive health and biological cycles as prohibited information.

What MedScale does

MedScale Health runs menopause and HRT accounts on Meta in two layers: care-layer campaigns that run now, and product campaigns in separate ad sets once LegitScript certification and Meta's authorization are in place, with MedScale's certification help covering the filing. Every ad and page is pre-checked against the rules above before it ships. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. No approval or result is guaranteed. Start with the free growth audit at medscale.health/audit.